News Headlines Article

FDA panel wants changes to Avandia safety measures
Modern Healthcare

Federal health experts have recommended changing safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as previously believed.

A majority of Food and Drug Administration advisers voted to modify or remove measures that currently limit patient access to GlaxoSmithKline’s Avandia. Among other rules, patients currently must sign a waiver that they understand the drug’s risks before getting a prescription. The drug can only be dispensed by specially registered pharmacies.